SCHEMBL6908302

SCHEMBL6908302

C1CCC(OC2CCCCO2)OC1.OCCCCCCCCCCCBr

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10765977 1.00 MEN1 (0.38) MEN1KMT2ATSHR
SCHEMBL28323877 1.00 MEN1 (0.38) MEN1KMT2ATSHR
SCHEMBL459271 0.93 TSHR (0.39) MEN1KMT2ATSHR
2-Bromoethanol SCHEMBL3055303 0.88 MEN1 (0.33) MEN1KMT2A
SCHEMBL8645521 0.87 KMT2A (0.51) MEN1KMT2ATSHR
SCHEMBL9879608 0.87 KMT2A (0.51) MEN1KMT2ATSHR
SCHEMBL11818110 0.81 MEN1 (0.33) MEN1KMT2A
SCHEMBL9661524 0.81 MEN1 (0.36) MEN1KMT2A
SCHEMBL10344326 0.80 MEN1 (0.36) MEN1KMT2A
SCHEMBL14151007 0.80 KMT2A (0.33) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0943328-B1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia ENDORECH INC (CA) 2004-06-16 EP disclosed
EP-0595796-B1 METHOD OF TREATMENT OF ANDROGEN-RELATED DISEASES ENDORECH INC (CA) 2003-01-15 EP disclosed
US-6423698-B1 ADMINISTERING INHIBITOR OF 17-BETA-HYDROXYSTEROID DEHYDROGENASE AND AT LEAST ONE OF AN INHIBITOR OF AROMATASE AND INHIBITOR OF 5-ALPHA-REDUCTASE ENDORECHERCHE, INC. (CA) 2002-07-23 US disclosed
US-6110906-A ANDROGEN RECEPTOR ANTAGONISTS, ANTICARCINOGENIC AGENTS; PROSTATE CANCER ENDORECHERCHE, INC. (CA) 2000-08-29 US disclosed
EP-0943328-A2 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia ENDORECHERCHE INC. (CA) 1999-09-22 EP disclosed
EP-0480950-B1 COMBINATION THERAPY FOR PROPHYLAXIS AND/OR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA ENDORECHERCHE INC (CA) 1999-03-24 EP disclosed
US-5817649-A Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia ENDORECHERCHE, INC. (CA) 1998-10-06 US disclosed
EP-0485392-B1 ANDROGEN DERIVATIVES FOR USE IN THE INHIBITION OF SEX STEROID ACTIVITY ENDORECHERCHE INC (CA) 1998-09-09 EP disclosed
EP-0857487-A2 Combinations for prophylaxsis and/or treatment of benign prostatic hyperplasia containing a 17 beta-hydroxy steroid dehydrogenase (17bHSD) inhibitor and at least one further active ingredient ENDORECHERCHE INC. (CA) 1998-08-12 EP disclosed
US-5610150-A Method of treatment of androgen-related diseases ENDORECHERCHE INC. (CA) 1997-03-11 US disclosed
US-5372996-A Method of treatment of androgen-related diseases ENDORECHERCHE, INC. (CA) 1994-12-13 US disclosed
EP-0615448-A1 SEX STEROID ACTIVITY INHIBITORS ENDORECHERCHE INC. (CA) 1994-09-21 EP disclosed
EP-0595796-A1 METHOD OF TREATMENT OF ANDROGEN-RELATED DISEASES ENDORECHERCHE INC. (CA) 1994-05-11 EP disclosed
WO-1993010741-A2 SEX STEROID ACTIVITY INHIBITORS ENDORECHERCHE INC. (CA) 1993-06-10 WO disclosed
EP-0485392-A1 ANDROGEN DERIVATIVES FOR USE IN THE INHIBITION OF SEX STEROID ACTIVITY ENDORECHERCHE INC. (CA) 1992-05-20 EP disclosed
EP-0480950-A1 COMBINATION THERAPY FOR PROPHYLAXIS AND/OR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA ENDORECHERCHE INC. (CA) 1992-04-22 EP disclosed
WO-1991000731-A1 COMBINATION THERAPY FOR PROPHYLAXIS AND/OR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA ENDORECHERCHE INC. (CA) 1991-01-24 WO disclosed
WO-1991000733-A1 METHOD OF TREATMENT OF ANDROGEN-RELATED DISEASES ENDORECHERCHE INC. (CA) 1991-01-24 WO disclosed
WO-1991000732-A1 ANDROGEN DERIVATIVES FOR USE IN THE INHIBITION OF SEX STEROID ACTIVITY ENDORECHERCHE INC. (CA) 1991-01-24 WO disclosed
US-4243660-A 11-HEXADECENYL AND 11-HEPTADECENYL ACETATE; SYNERGISTIC EGYT GYOGYSZERVEGYESZETI GYAR (HU) 1981-01-06 US disclosed